As IGF1 has long been implicated in various tumorigeneses, including pancreatic cancer, breast cancer, Ewing sarcoma, and melanoma, several small molecules and monoclonal antibodies targeting IGF1 signaling have been developed (57, 58). This evidence concerns the gene IGF1 and familial pancreatic carcinoma.